"Our focus is getting the product on the market, and we have all the capabilities in-house to register and commercialize innovative pharmaceuticals in Canada."
Valeo Pharma Inc. has built its business on a foundation of strong partnerships with International Pharmaceutical Companies. We look for partners with world class R&D and state of the art manufacturing facilities to complement our own internal capabilities. By having all resources and expertise under management to register and market innovative products, we have the flexibility and know-how to maximize the potential of our partnerships.
While the decision is always driven by the product, our primary areas of expertise and focus include:
- Neurodegenerative Diseases
- Oncology and Supportive Care
- Hospital Products
Valeo Pharma's portfolio consists of innovative products that provides better options the Canadian doctors and specialist, and ultimately, improves the lives of Canadian patients. If you have innovative products registered or approved in territories outside of Canada, or in late Phase III Clinical studies, and are interested in partnering for launch in Canada, we look forward to the opportunity of discussing why Valeo Pharma should be your partner of choice for Canada.
If you are interested in discussing potential business opportunities, please contact
Jeffrey Skinner - Vice President, Business Development